Thermo Fisher Scientific Showcases Range of Clinical Diagnostics Solutions at American Association for Clinical Chemistry 2008

WASHINGTON--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today showcased a range of innovative solutions for clinical applications at the American Association for Clinical Chemistry’s (AACC’s) 2008 Annual Meeting, underscoring its top-10 position in the clinical diagnostics market. The company’s technologies enable improved productivity in the clinical laboratory through a range of sample preparation and analysis tools, immunoassays for therapeutic drug monitoring and instrumentation for advanced analysis of biological samples.
MORE ON THIS TOPIC